Skip to content
lifestyle.hubspotes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vivos Therapeutics, Inc
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
June 22, 2026
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
June 11, 2026
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
June 10, 2026
Vivos Therapeutics Reports Full Year 2025 Financial Results
April 16, 2026
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
April 15, 2026
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
April 7, 2026
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved ‘In-Network’ Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
March 26, 2026
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
March 17, 2026
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
February 11, 2026
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
January 20, 2026